Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?
Several epidemiological studies suggest that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) may protect subjects carrying one or more ε4 allele of the apolipoprotein E (APOE ε4) against the onset of Alzheimer’s disease (AD). The biological mechanism...
Main Authors: | Bruno P Imbimbo, Vincenzo Solfrizzi, Francesco Panza |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2010-05-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2010.00019/full |
Similar Items
-
NSAIDs: how they work and their prospects as therapeutics in Alzheimer's disease
by: Steve M Gentleman
Published: (2010-05-01) -
18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
by: Yan Chang, et al.
Published: (2020-07-01) -
Microglia function in Alzheimer’s disease
by: Egle eSolito, et al.
Published: (2012-02-01) -
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
by: Justyna Sosna, et al.
Published: (2018-03-01) -
CALCIUM-SENSING RECEPTORS OF HUMAN NEURAL CELLS PLAY CRUCIAL ROLES IN ALZHEIMER’S DISEASE
by: Anna eChiarini, et al.
Published: (2016-04-01)